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Abstract. This study focuses on pattern recognition in pathology data collected from patients tested
for Chlamydia pneumoniae (Cp) infection, with co-infection by Mycoplasma pneumoniae (Myco) also
considered. Both Cp and Myco are microbes that cause respiratory disease in some infected people. As
well as the immunoassay results revealing whether the patient had been infected, or not, an extensive
range of other routine pathology data was also available for each patient, allowing the analysis of
associations between a positive immunoassay laboratory result for Cp or Myco, and a range of tests for
biochemical and cellular markers (e.g. liver enzymes, electrolyte balance, haematological indices such as
red/white cell counts). Decision trees and logistic regression were used to enhance laboratory diagnosis of
these respiratory infections via the formulation of association rules derived from immunoassay results and
associated pathology data.
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Introduction

This study is based on the application of standard statistical methods to clinical pathology databases to
recognise patterns that will identify small groups in the population that are at higher relative risk of
infection by the respiratory pathogens Chlamydia pneumoniae (Cp) and/or Mycoplasma pneumoniae
(Myco). Once rules have been discovered, they can be used to develop a system of electronic alerts that
will identify patterns of pathology results that identify a patient at a high relative risk of a true infection
through enhancing the predictive capacity of combined laboratory test results.
Chlamydia species are obligate intracellular bacteria responsible for atypical pneumonia, sexually
transmitted disease or eye infection in humans. [1]. Mycoplasma pneumoniae is also an obligate
intracellular bacteria, and unusual in comparison to other bacteria in that it lacks a cell wall and has a
less sophisticated internal organisation. Mycoplasma (Myco) infection is associated with respiratory
disease in humans, which can also lead to extrapulmonary complications and hospitalisation in some
cases [2].
The aims of this study were:
•
•
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To enhance the predictive power of routinely performed diagnostic pathology laboratory results
by combining multiple tests on individual patients and taking into account the reliability of each
test as an individual disease marker.
To discover patterns (grouping of pathological assays) within routinely collected diagnostic
pathology tests and use these to identify the characteristics of patient groups at higher relative
risk of infectious respiratory diseases.
The Data

The data used in this study was obtained from de-identified data extracted from ACT Pathology
Laboratory databases (The Canberra Hospital). Variables with missing values were removed as the
analysis methods used for this study required complete data. Patients with multiple entries (for the
same lab test) were removed to ensure that the analysis related solely to single-visit patients. The
selected variables used for building the models are summarised in Table 1.
M. Chetty, S. Ahmad, A. Ngom, S. W. Teng (Eds.): PRIB2008,
Supplementary Conf. Proc., pp.227-234, 2008.
(c) PRIB 2008
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Table 1. Pathology laboratory variables used in model building for the study of Chlamydia pneumoniae infection
in patients who were tested by ACT Pathology, the Canberra Hospital

Response
Variables
IgA
Myco
Predictor
variables
Age
Sex
Na+
(defined as Nas
in section 3.1)
Urea
Crea
ALT
GGT
Hb
RCC
MCV
Hct
RDW
MCH
MCHC
Total WCC
Plt
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Description
Antibody specific for Cp; presence of antibody means previous Cp infection
Serum IgG titre against the microbe Myco; presence means previous Myco infection
Description
Patient’s age in years
Patient’s gender
“Salt” in the serum. With potassium (K+), chloride (Cl-) etc., known as
“electrolytes”. Helps with assessment of physiological water balance and kidney
function
Waste product of nitrogen metabolism; measures kidney function
Creatinine (also a waste product of nitrogen) that helps with the assessment of
kidney function
Alanine aminotransferase (an intracellular enzyme released in high concentrations
after liver damage)
Gamma-glutamyl transferase (an intracellular enzyme like ALT - also relevant to
liver function)
Haemoglobin (Oxygen carrying pigment of red blood cells)
Red cell count (Red cells also called red blood cells or erythrocytes)
Mean corpuscular volume (average red cell volume - helps diagnosis of anaemia)
Haematocrit (formerly known as “packed cell volume”) is a measure of cell density
in a blood sample. It helps in the diagnosis of certain anaemias.
Red cell distribution width
Mean corpuscular haemoglobin (average concentration of Hb per red cell)
Mean corpuscular haemoglobin concentration (a parameter calculated from MCH.
Like MCH, MCV and RCC, assists with the diagnosis of anaemia)
White cell count (White cells such as lymphocytes and monocytes form the cellular
component of the immune response. Elevated with infection or allergy)
Platelets (which are cell fragments involved in blood clotting)

Enhanced Predictors for Diagnosis of Chlamydia Pneumoniae

Two standard statistical methods were applied to the data: decision trees [3] and logistic regression.
These were chosen on the basis of their widely-studied statistical properties and the clear indications
they give of which variables are important in the finals decision-making process. Both these methods
require a complete data set with no missing observations for accurate analysis and pattern recognition.
This requirement, along with the data pre-processing mentioned in Section 2, reduced the data set to
1495 individuals, all with the complete set of response and predictor variables defined in Table 1. On
the basis of the value of IgA, there were 649 individuals with a clear positive serological test for Cp, 82
indeterminate results and 764 clear negatives. The basis of deciding on whether a result was clear
positive, negative or indeterminate, was guided by internal ACT Pathology quality control protocols
and reference ranges for Cp serology.
3.1

Decision tree

A decision tree model was fitted using the binary recursive-partitioning (RPART) algorithm in R 2.6.1.
A pattern recognition model in the healthcare sector ideally needs to be able to deal with ever
increasing amounts of data, especially in the complex field of bioinformatics. Decision tree models are
able to accept numerous input variables and provide good explanation capability on how to recognise a
pattern. Figure 1 shows the tree produced for all 1495 patients: no pruning was required. The numbers
in the ovals and rectangles are the predicted outcome for patients at that node (1 = negative, 2 =
indeterminate, 3 = positive). Table 2 shows a summary of the main path through the tree, with
associated probabilities.
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Fig. 1. Decision tree for all patients (n = 1495) tested for Cp infection

The main path through the decision tree is to the right. It is interpreted as follows. There is a 43%
chance of a patient testing positive for Cp. If we also learn that the patient is ≥ 38.5 years old, the
chance that the patient will test positive is now 50%. If we also learn that the patient has GGT ≥
38.5U/L, the chance that the patient will test positive increases again to 55%. Table 2 shows these
increases in percentage. Other paths in the tree can be interpreted in a similar fashion.
Table 2. Positive tests in the decision tree for all Cp patients

Rule
Initial group
Age ≥ 38.5
GGT ≥ 38.5

Percentage testing positive under this accumulation of rules
649/1495 = 43%
523/1044 = 50%
341/618 = 55%

Given the importance of age as a determining variable in Cp infection emerging from this decision tree,
we next fitted two decision trees for older and younger patients separately. Figure 2 and Table 3 show
the results for patients older than 38 years. The tree was pruned using a complexity parameter of 0.01.

3
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Fig. 2. Decision tree for patients older than 38 years (n = 1044) tested for Cp infection.

The main path through the decision tree is to the right once again. It is interpreted in a similar fashion
to Figure 1, and the increases in percentage is shown in Table 3.
Table 3. Positive tests in the decision tree for Cp patients over 38 years of age

Rule
Initial group
GGT ≥ 38.5
Na+ ≥ 136.5
RDW ≥ 12.15

Percentage testing positive under this accumulation of rules
523/1044 = 50%
341/618 = 55%
262/436 = 60%
261/426 = 61%

Figure 3 and Table 4 show the results for patients 38 years of age and under. The tree was pruned using
a complexity parameter of 0.02.

Fig. 3. Decision tree for patients 38 years of age and under (n = 451) tested for Cp infection

Table 4. Positive tests in the decision tree for Cp patients 38 years of age and under

Rule
Initial group
Age ≤ 14.5
Plt < 262.5
Total WCC ≥ 9.3
Hb ≥ 132.5
RDW ≥ 12.65

Percentage testing positive under this accumulation of rules
126/451 = 28%
114/360 = 32%
72/179 = 40%
39/73 = 53%
35/55 = 64%
31/41 = 76%

The main path through the decision tree is to the right once again. It is interpreted in a similar fashion
as Figures 1 and 2.
3.2

Logistic regression in the Chlamydia data set
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Logistic regression was used to predict the likelihood (%) of a clear positive for Cp infection (as
informed by serology/immunoassay - regular quality control by ACT Pathology ensures accurate Cp
immunoassay data, within two standard deviations). Since logistic regression requires two outcomes
(positive or negative), indeterminate IgA was combined with negative IgA.
The logistic regression modelling was done in R 2.6.1. The final model, in terms of log odds of being
IgA positive, is:
log(P(IgA positive)/1 - P(IgA positive)) =
-2.72 + 0.02 Age – 0.42 (Sex = M) + 0.001 ALT + 0.017 MCV.
In general, the coefficients in the logistic model estimate the change in the log odds of IgA positive
when a variable is increased by 1 unit, holding all the other variables in the model fixed. The
exponentials of the coefficients estimate the change in the odds-ratio of IgA positive when a variable is
increased by 1 unit, holding all the other variables in the model fixed.
This means that;
a. When all variables are set to 0, and holding all other variables constant,
the odds of an IgA positive result is 0.066
b. For every extra year of age, there is a 2% increase in the odds of Cp IgA positive
c. For males compared to females, there is a 34% decrease in the odds of Cp IgA positive
d. For each extra unit of ALT, there is a 0.1% increase in the odds of Cp IgA positive
e. For each extra unit of MCV, there is a 2% increase in the odds of Cp IgA positive
The p-values for the coefficients are shown in Table 5.
Table 5. Coefficient p-values for variables included in logistic regression model of Cp infection

Variable
Intercept
Age
Sex = M
MCV
ALT

p-value
0.0008
0.0000
0.0000
0.0524
0.0684

The order of significance of the variables is Age, Sex, MCV and ALT. This correlates broadly with the
decision tree results, where Age was the first variable on which decision-making was based, and a liver
function variable was also important (GGT in two of the decision trees and ALT in the logistic
regression.)
The area under the ROC curve (Figure 4) is 0.6424. This suggests that the model is able to explain
approximately two-thirds of the variation in the data. This is not a high value but is nonetheless an
improvement over the baseline value of 50%.

5

232

Fig. 4. Receiver Operating Characteristic (ROC) curve for the logistic regression model of Cp infection
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Discussion

The logistic regression shows Age, Sex, ALT and MCV as key markers with which to predict a
positive serology result for Cp. A limitation of this study was that apart from Myco serology, there
were no results to indicate whether the patients were infected, or not, with other respiratory pathogens,
for example influenza virus, rhinoviruses, coronaviruses, Streptococcus sp. and so on. For the purpose
of this report, it is assumed that the patients are not infected with other pathogens (patients who were
positive for both Cp and Myco were excluded from the above analyses).
Age was divided as either ≥ or < 15 years of age. Access to larger data sets will allow an enhanced age
analysis. In general, as the immune system matures (which should happen around 12-15 years of age),
the majority of infectious agents are likely to have been encountered and immunological memory
established. For the purposes of this study, this is a generalisation that does not take into account the
large genetic diversity in immune genes and immune gene expression for human populations, and
hence, variable immune responses between individuals. However, age effect and susceptibility to
disease post infection has been recognised, for example, with the arthrogenic Australian alphavirus,
Ross River (RRV). Disease post RRV infection is generally only seen in people between 20 and 60
years of age [4].
The liver function test marker, ALT, was implicated in logistic regression analysis as associated with a
greater probability of a positive serology result for Cp. Further analysis requires access to additional
liver function data to decide whether liver involvement is physiologically associated with Cp infection,
and not simply a mathematical association. Analysis of the biomedical literature has not found any
comprehensive clinical or pre-clinical studies of Cp infection indicating liver sequelae. However, a
case study on a patient suffering from severe Cp-associated disease has reported abnormal liver
enzymes and other markers of liver function in routine pathology analysis of this patient’s serum [5].
Another study has isolated Chlamydia trachomatis from a liver biopsy of a patient who had a 10-month
history of chills, fever and abdominal pain. The biopsy result showed inflammatory infiltrates in the
portal tracts, and serum analysis detected elevated alkaline phosphatase (ALP) and 5'-nucleotidase [6].
Case study reports have also linked Mycoplasma infection to abnormal liver function test results [7, 8].
In the context of this study, further investigations are required with markers of true liver function (e.g.
serum albumin, bilirubin) to determine a pathological connection of Cp and Myco infection with liver
function.
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An unexpected result of the analyses showed MCV and RDW as factors contributing to the enhanced
likelihood of a positive Cp serology test result. Explanation for this result can broadly refer to possible
anaemia as a symptom of Cp infection or pathology, although it would be expected that other red cell
markers would also feature as important in the mathematical results, as MCV results are calculated
from other measured red cell parameters (Table 1). The involvement of MCV as a marker for Cp
infection can be explained by the results of a study from Al Younes et al. [9]. This study reported that
Cp can sequester iron (Fe+++) from the infected patient, and that iron availability modulates the course
of Cp infection. Iron is found in abundance in the red cell pigment haemoglobin. With the Cp microbe
capable of utilising patient iron, it is likely that variability in red blood cell parameters will occur and
hence be a positive factor in the enhanced prediction of Cp infection, in addition to Cp antibody testing
by immunoassay in the laboratory.
The results of this study provide good indications of biomedical associations for the laboratory
diagnosis of Cp infection, leading to enhanced prediction of true positive results for Cp via pattern
recognition in routine pathology data. Extended analysis of the data could include comparison of the
rules from the methods presented here with results from techniques such as support vector machines
[10, 11]. It is possible that such methods may yield stronger results in terms of ROC, for example, but
these may come at the cost of transparency of which markers are important in decision-making. Future
uses of analyses could also include:
• Use of the discovered clinical rules to develop a prototype expert system to flag patients at
higher relative risk of viral diseases.
• Link database analyses to patient gene transcript profiles to further augment the diagnostic
power of this strategy.
Future work will also benefit from the provision of extra data for each anonymous patient in the
original data set. For example, the analyses thus far have indicated a consistent association of a positive
Cp serology result with the routine liver (enzyme) markers alanine aminotransferase (ALT) and
gamma-glutamyl transferase (γGT). Whether this association is incidental, or truly reflects an impact of
infection on liver function, requires data for additional laboratory markers of true liver function. Given
the inflammatory nature of respiratory infection by Cp, the inclusion of data for C-Reactive Protein
(CRP) will also be beneficial.
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